Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析

◆英語タイトル:Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013736
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Oriola-KD Oyj (OKDBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oriola-KD Oyj (Oriola-KD) is a retail and wholesale company which distributes pharmaceuticals and health and wellbeing products. It offers expert advice on health and wellbeing and quality products through pharmacies. The company provides wide service offerings covering pharmaceutical distribution, branded products and other tailored services to healthcare operators. Its product portfolio includes vitamins, pharmaceutical cosmetics, skincare products, tests, dietary supplements, sports drinks, wound care products and other related products under Avene, Gefilus, Lysi and Oriola’s brands. It also provides pharmaceutical distribution services and a range of value adding services from clinical research to consumer services to pharmacies, pharma companies, veterinarians and grocery stores. Oriola-KD also maintains partnerships with other pharma companies to distribute several drugs in Finland, Sweden, Estonia, Latvia, Lithuania and Russia. Oriola-KD is headquartered in Espoo, Finland.

Oriola-KD Oyj Key Recent Developments

Oct 25,2017: Oriola: Interim Report January-September 2017
Oct 12,2017: Oriola third quarter result impacted by distribution disruptions in Finland
Jul 21,2017: Oriola’s Half Year Financial Report January-June 2017
Jul 13,2017: Oriola revises guidance for continuing operations adjusted operating profit
Jul 07,2017: Changes in Oriola’s Group Management Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Oriola-KD Oyj – Key Facts 5
Oriola-KD Oyj – Key Employees 6
Oriola-KD Oyj – Key Employee Biographies 7
Oriola-KD Oyj – Major Products and Services 8
Oriola-KD Oyj – History 9
Oriola-KD Oyj – Company Statement 10
Oriola-KD Oyj – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Oriola-KD Oyj – Business Description 12
Oriola-KD Oyj – Corporate Strategy 13
Oriola-KD Oyj – SWOT Analysis 14
SWOT Analysis – Overview 14
Oriola-KD Oyj – Strengths 14
Oriola-KD Oyj – Weaknesses 15
Oriola-KD Oyj – Opportunities 16
Oriola-KD Oyj – Threats 17
Oriola-KD Oyj – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Oriola-KD Oyj, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Oct 25, 2017: Oriola: Interim Report January-September 2017 29
Oct 12, 2017: Oriola third quarter result impacted by distribution disruptions in Finland 31
Jul 21, 2017: Oriola’s Half Year Financial Report January-June 2017 32
Jul 13, 2017: Oriola revises guidance for continuing operations adjusted operating profit 33
Jul 07, 2017: Changes in Oriola’s Group Management Team 34
Jun 22, 2017: Oriola has rearranged its long-term revolving credit facility and term loan agreement 35
Apr 28, 2017: Oriola Interim Report for 1 January – 31 March 2017 36
Feb 13, 2017: Oriola-KD’s Financial Statements Release 2016 39
Oct 20, 2016: Oriola-KD Interim Report for 1 January-30 September 2016 41
Sep 07, 2016: Terhi Kivinen Appointed Group Communications Director, Oriola-Kd Corporation 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Oriola-KD Oyj, Key Facts 5
Oriola-KD Oyj, Key Employees 6
Oriola-KD Oyj, Key Employee Biographies 7
Oriola-KD Oyj, Major Products and Services 8
Oriola-KD Oyj, History 9
Oriola-KD Oyj, Subsidiaries 11
Oriola-KD Oyj, Key Competitors 18
Oriola-KD Oyj, Ratios based on current share price 19
Oriola-KD Oyj, Annual Ratios 20
Oriola-KD Oyj, Annual Ratios (Cont...1) 21
Oriola-KD Oyj, Annual Ratios (Cont...2) 22
Oriola-KD Oyj, Interim Ratios 24
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Oriola-KD Oyj, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Oriola-KD Oyj, Recent Deals Summary 28
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

★海外企業調査レポート[Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hamburg Commercial Bank:企業の戦略・SWOT・財務分析
    Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary Hamburg Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Goodrich Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive in …
  • Medical Research Council-製薬・医療分野:企業M&A・提携分析
    Summary Medical Research Council (MRC) is a human health research council that offers medical research programs. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides data management, research platform, tools and facilities to g …
  • Strukton Groep NV:企業の戦略・SWOT・財務情報
    Strukton Groep NV - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kuoni Travel Holding Ltd.:企業のM&A・事業提携・投資動向
    Kuoni Travel Holding Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kuoni Travel Holding Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Strabag International GmbH:企業の戦略的SWOT分析
    Strabag International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • IMI plc:企業の戦略・SWOT・財務分析
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Caladrius Biosciences Inc (CLBS):製薬・医療:M&Aディール及び事業提携情報
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a cell therapy service provider. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. It offers products to target type one diabetes mellitus, used to treat imbalance in …
  • VINCI Energies:電力:M&Aディール及び事業提携情報
    Summary VINCI Energies S.A. (Vinci), a subsidiary of Vinci SA, is a provider of energy efficiency and renewable energy solutions. The company offers heating, ventilation and air conditioning, electric power, mechanical engineering and information and communications technologies. Vinci operates in mu …
  • Chimab SpA:企業の戦略・SWOT・財務情報
    Chimab SpA - Strategy, SWOT and Corporate Finance Report Summary Chimab SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vilniaus Degtine AB:戦略・SWOT・企業財務分析
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IFFCO-Tokio General Insurance Co. Ltd.:企業の戦略・SWOT・財務情報
    IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary IFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Ferring Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ferring Pharmaceuticals Inc (Ferring), a subsidiary of Ferring International Center SA is a biopharmaceutical company that conducts research and development services. The company develops peptide-based drugs and biotechnology derived medicines. It also develops effective and patient-friendly …
  • Taiho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic age …
  • Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against impor …
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • GOBARTO S.A.:企業の戦略・SWOT・財務情報
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務分析
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆